Tim Shaw Email & Phone Number

London, United Kingdom

Global Medical Affairs lead for rheumatoid arthritis

Independent Pharmaceutical Consultant providing support to Clinical development and Medical Affairs. Currently assisting clients with lead indication identification and early clinical development scenarios in preparation for venture capital investment, as well as study design and protocol development. Areas in which I can offer support include:Strategic.

Within inflammation/immunology, responsible for all post approval data generation activities for apremilast (Otezla) in psoriatic arthritis and psoriasis, including Phase IV strategy and design, real-world data collection via registries, non-interventional, observational studies and investigator initiated research. European Medical Affairs team responsible.

Responsible for all local Medical Affairs activities for inflammation/immunology within UK/IRE, Nordics and Netherlands. Key activities included establishing Celgene as a new partner within immune-inflammatory disease area, UK strategic and tactical plan, advisory boards, KOL relationship management, and local congress exhibition presence (including.

Accountable for medical science team responsible for all clinical activities for rituximab (MabThera®) in rheumatoid arthritis, including clinical development plan (Phase II-IV), study protocols, medical data review, analysis plans, study reports and regulatory clinical documents (including briefing packages, integrated summaries, clinical overview, label.

From 1988 - 1994 held variety of positions within clinical development including Clinical Operations (Clinical Reseach Associate, Clinical Project Co-ordinator) and early clinical development (Clinical Pharmacologist responsible for Phase I studies including entry in to humans).